Poxel’s Diabetes Drug Wins Japan Nod, But Competition Remains Fierce
As French biotech Poxel marks the first market approval of its oral type 2 diabetes…
02/07/2021 - 5 minutes
Poxel
The Top 10 Biotechs You’ll Find in Lyon
Lyon is one of the hotspots for biotech in Europe. Here are 10 of the…
10/07/2019 - 6 minutes
French First-in-Class Diabetes Drug Nails Phase III Trial
An oral first-in-class drug targeting the mitochondria, developed by the French biotech Poxel, has shown…
09/04/2019 - 3 minutes
French Biotech Takes its Oral Diabetes Drug to Phase III
Update (13/03/2018): Poxel has started two more Phase III trials in Japan testing its drug…
13/03/2018 - 3 minutes
Healthcare-Biotech Partnership Pledges to Take its Type 2 Diabetes Treatment Worldwide
Swiss pharma Roivant has given French biotech Poxel €28M upfront to get involved with the development…
12/02/2018 - 3 minutes
Stories We Didn’t Cover: Next Human CRISPR Trials by Intellia?
Try as we might, we can't cover all the biotech news out there. During the…
09/12/2016 - 2 minutes
Poxel raises €26.5M to support Phase III trial in Diabetes
Poxel has closed a capital increase on the Euronext Paris, raising €26.5M. The money is…
19/07/2016 - 2 minutes
Poxel is Looking towards Japan’s Lucrative Diabetes Market
Poxel, the French company that made a €27M IPO last February, announced the successful conclusion…
29/05/2015 - 2 minutes
After its IPO, Poxel maintains its promise to develop a new Type 2 diabetes drug
Poxel continues to interest the market after its successful IPO in February 2015, where it…
03/05/2015 - 3 minutes
